Industry News
ComBio 2003: The hard truth about salt resistance
'Durum' means 'hard' in Latin -- but for wheatgrowers who have tried to grow high-value, high-protein durum wheats in the semi-arid regions of Victoria, SA an WA semi-arid zone, durum wheats are in the too-hard basket. [ + ]
Biotech demand will continue to grow: analyst
The recent upswing in biotech share prices has acted as a trigger point for the increase in investment in the sector, according to sector analyst and BioShares co-editor David Blake. [ + ]
IDG Life Sciences to launch new magazine
October marks the culmination of our plans to develop a comprehensive suite of life science media products for the Australian market place. Australian Biotechnology News is now well entrenched as the newspaper of choice for local biotechnology leaders. And our acquisition of Today's Life Science has given us great depth across the sector. [ + ]
Ventracor to benefit from US reimbursement decision
A United States decision to approve reimbursement of Ventricular Assist Devices has come as good news to Australian artificial heart developer Ventracor (ASX:VCR). [ + ]
pSivida raises $6.5m, raises stake in UK subsid
Biomedical nanotechnology company pSivida (ASX:PSD) will strengthen its stake in its United Kingdom operating subsidiary following a AUD$6.5 million capital raising, the biotech announced today. [ + ]
Optiscan receives first Pentax order
Optiscan Imaging's (ASX: OIL) partnership with Japan's Pentax Corporation to develop a flexible endomicroscope has taken another step forward with the Melbourne biotech receiving its first major order for the supply of components. [ + ]
Biota strengthens Sankyo agreement
Biota Holdings' (ASX:BTA) second-generation influenza program has leap-frogged into clinical trials thanks to a partnership with a Japanese competitor. [ + ]
New ARC scheme aims to create research networks
The Australian Research Council has launched a new program aimed at encouraging the development of research networks, and fostering interdisciplinary research. [ + ]
UK investors double EQiTX war chest
Technology investment company EQiTX (ASX:EQX) has more than doubled its cash reserves with a successful AUD$2.7 million capital raising, raised mostly through investors in the United Kingdom. [ + ]
BioDiem options eye treatment peptide
Melbourne pharmaceutical development company BioDiem has taken an option over research involving the use of a peptide to treat major retinal diseases and age-related blindness. [ + ]
ComBio: Memories are made of this
It seems that memories are made of... cadherins. While cadherins -- cell adhesion molecules -- do not actually store memories, at the very least they have a major role in organising the basic architecture of the brain, and the dense filigree of fine neural interconnections in which memories are mysteriously stored. [ + ]
ComBio: Unravelling the subtleties of telomerase
The telomeres are intriguing repetitive structures found on the chromosome tips, which are responsible for preventing the gradual erosion of the ends of the chromosomes. [ + ]
Monsanto opens Qld research centre
Monsanto has opened a biotechnology research centre in Queensland to support its cotton product stewardship program. [ + ]
VRI Biomedical completes Progastrim study
VRI Biomedical has completed a preliminary study demonstrating that their probiotic product Progastrim, which contains a proprietary strain of Lactobacillus fermentum, reduced respiratory symptoms in elite athletes. [ + ]
Researchers call for FMD vaccine project
Britain's disastrous epidemic of foot and mouth disease (FMD) in 2001 cost the UK economy an estimated AUD$18 billion, and confirmed the what international veterinary authorities had feared: their insurance against the world's worst livestock disease had lapsed. [ + ]